AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BerGenBio

Report Publication Announcement Feb 5, 2019

3555_rns_2019-02-05_22630c56-ba83-466a-b379-8b8f7057d00a.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

BerGenBio ASA: Invitation to Fourth Quarter and Full Year 2018 Results Presentation and Webcast

BerGenBio ASA: Invitation to Fourth Quarter and Full Year 2018 Results Presentation and Webcast

Bergen, Norway, 05 February 2019 - BerGenBio ASA (OSE:BGBIO), will announce its

results for the fourth quarter and full year 2018 on Tuesday, 12 February 2019.

A presentation by BerGenBio's senior management team will take place at 10:00 am

CET at:

Hotel Continental

Stortingsgaten 24/26

0117 Oslo

The presentation will webcast live and the link will be available at

www.bergenbio.com in the section Investors/Financial Reports. A recording will

be available shortly after the webcast has finished.

The results report and presentation will be available at www.bergenbio.com in

the section: Investors/Financial Reports from 7:00 am CET the same day.

-Ends-

Contacts

Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Rune Skeie

CFO, BerGenBio ASA

[email protected]

+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not

historical facts, but are based upon various assumptions, many of which are

based, in turn, upon further assumptions. These assumptions are inherently

subject to significant known and unknown risks, uncertainties and other

important factors. Such risks, uncertainties, contingencies and other important

factors could cause actual events to differ materially from the expectations

expressed or implied in this announcement by such forward-looking statements.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.